Company profile
Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the
- CEO
- Mr. Yong Qi Quek
- Headquarters
- Singapore, Singapore
- Employees
- 10
- IPO date
- Apr 10, 2025
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies